ArticleCell reports. Medicine2026

An aerosolized dual-action autotaxin inhibitor-PPARγ agonist for the treatment of pulmonary fibrosis.

Alexios N Matralis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.